What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy

As of the April 24 closing, the statement sentiment astir the banal was powerfully bullish. It received Buy ratings from each 12 analysts who provided coverage. Moreover, it offers astir 150% upside potential, based connected a median 1-year terms people of $64.45, making it 1 of the astir charismatic small-cap picks.

Pressmaster/Shutterstock.com

The bullish views are besides backed by the company’s latest proceedings outcomes. Back connected March 25, Maze Therapeutics Inc. (NASDAQ:MAZE) revealed encouraging results from the Phase 2 HORIZON proceedings connected MZE829, an oral cause inhibiting APOL1, successful treating a scope of APOL1-induced kidney diseases. 12 weeks of medication of the cause brought astir a 35.6% simplification successful the mean worth of albumin/creatinine ratio successful wide AMKD patients, wherever 50% of patients had a simplification exceeding 30%.

Patients diagnosed with FSGS information recorded a simplification successful mean worth by 61.8%, portion those suffering from non-diabetic AMKD saw a simplification by 48.6%. There were nary terrible broadside effects. Maze intends to determination the cause into a pivotal program. Harold Bernstein, President of R&D and Chief Medical Officer, stated that the results show encouraging impervious of conception for the precision medicine treating the origin of AMKD.

Maze Therapeutics Inc. (NASDAQ:MAZE) is simply a developer of small-molecule precision medicines for the attraction of kidney and metabolic illnesses. The company’s pb programs see MZE829, APOL1, and MZE782. Additionally, it is besides progressive successful the improvement of MZE001. The institution has agreements with assorted organizations for licensing and commercialization of its products.

While we admit the imaginable of MAZE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.